Coignard, J.,
Lush, M.,
Beesley, J.,
O’Mara, T.A.,
Dennis, J,
Tyrer, J.P.,
Barnes, D.R.,
McGuffog, L.,
Leslie, G.,
Bolla, M.K.,
Adank, M.A.,
Kiiski, J.I.,
Nevanlinna, H.,
team of authors (2021) , were identified in general population studies. Other mutation carrier-specific
susceptibility variants
Yunusbaeva, M.,
Borodina, L.,
Alekseev, P.,
Davydov, R.,
Sharipov, R.,
Bilalov, F.,
Yunusbayev, B. (2019) efficacy of patients with multidrug-resistant (MDR), extensively drug-resistant (XDR) and drug-
susceptibleTimasheva, Y,
Badykov, M,
Akhmadishina, L,
Nasibullin, T,
Badykova, E,
Pushkareva, A,
Plechev, V,
Sagitov, I,
Zagidullin, N (2021) findings suggest that KCNE1 rs1805127 polymorphism may play a role in
susceptibility to sinoatrial node
Yanchao, L.,
Sibin, Z.,
Gareev, I.,
Huan, X.,
Junfei, Z.,
Chunyang, L.,
Beylerli, O.,
Sufianov, A.,
Chao, Y.,
Yuyan, G.,
Xun, X.,
Ahmad, A. (2022) atherosclerosis patients and the
susceptibility of carotid atherosclerosis patients to COVID-19. Potential
for differentially expressed genes (DEGs) in ICH. Online analysis tool GEO2R and Drug
Susceptibility Assessment